From: IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
Nr | Trial | Population | Sample size |
---|---|---|---|
1 | Amphia | Women with a multiple pregnancy before 20 weeks pregnancy | 720 |
2 | Hypitat II | Women with pregnancy induced hypertension or mild pre-eclampia at 34-37 weeks gestation | 400 |
3 | Digitat | Women with a singleton pregnancy at 36 completed weeks of gestation or more | 626 |
4 | Ppromexil | Women with preterm prelabour rupture of membranes between 34 and 37 weeks gestation | 520 |
5 | Stan | Women in labour over 36 weeks of gestation with an indication for CTG monitoring | 2400 |
6 | Apostel 1 | Women with threatened preterm labour at 24-34 weeks gestation. | 220 |
7 | Apostel 2 | Women with threatened preterm labour at 26-32+2 weeks gestation. | 400 |
8 | TRIPLE P | Women with a singleton pregnancy | 1920 |
9 | Probaat | Women ≥ 37 weeks of gestation and Bishop score < 6 | 812 |
10 | PreCare | Women with preeclampia or HELLP in previous pregnancy | 250 |
11 | WOMB | Women with >1000 mL postpartum fluxus | 400 |
12 | Truffle | Women at 26-32 weeks gestation with a fetus with intrauterine growth retardation. | 500 |
13 | Allo | Women with suspected fetal asphyxia during labour | 220 |
14 | ProTWIN | Women with a multiple pregnancy between 12 and 20 weeks gestation | 660 |
15 | Metex | Women with an extra uterine gravidity | 72 |
16 | ESEP | Women with an extra uterine gravidity in one of the tubae and a normal contralateral tuba | 450 |
17 | INeS | Couples with unexplained subfertility or a mild male factor | 600 |
19 | MOVIN' | Women with anovulation not pregnant after 6 ovulatory cycles of clomid | 200 |
20 | Bedrest | Women who undergo intra-uterin insemination | 250 |
21 | VUSIS 1 | Women with stress-incontinence | 100 |
22 | PORTRET | Women with stress incontinence aged 35-80 years | 400 |
23 | CUPIDO | Women with vaginal prolaps | 114 |
24 | Pompoen | Women with postmenopausal bleeding | 200 |